Prokidney (PROK) Other Working Capital Changes (2021 - 2026)
Prokidney's (PROK) quarterly Other Working Capital Changes came in at -$1.7 million in Q2 2026, down 13.92% year-over-year from -$1.9 million in Q2 2025, and down 175.53% quarter-over-quarter from -$609000.0 in Q1 2026.
Analysis
Prokidney (PROK) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Other Working Capital Changes for 6 consecutive years, with -$1.7 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Other Working Capital Changes fell 13.92% year-over-year to -$1.7 million in Q2 2026; TTM through Jun 2026 was -$1.3 million, a 82.17% increase from a year earlier, with the FY2025 full-year figure at -$6.2 million, down 204.72% from the prior year.
- Other Working Capital Changes was -$1.7 million for Q2 2026 at Prokidney, down from -$609000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $6.7 million in Q2 2024 and troughed at -$5.7 million in Q1 2025.
- A 5-year average of $833.33 and a median of -$59000.0 in 2023 frame the typical range for Other Working Capital Changes.
- Across the five-year window, Other Working Capital Changes soared 448.17% in 2024 and sank 915.78% in 2025, its largest moves.
- Over 5 years, Other Working Capital Changes stood at $1.4 million in 2022, then sank by 68.61% to $446000.0 in 2023, then slumped by 668.16% to -$2.5 million in 2024, then soared by 161.52% to $1.6 million in 2025, then slumped by 207.63% to -$1.7 million in 2026.
- The last three Other Working Capital Changes figures came in at -$1.7 million (Q2 2026), -$609000.0 (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.68 Mn |
| Jun 30, 2026 | -1.68 Mn |
| Mar 31, 2026 | -609,000.00 |
| Mar 31, 2026 | -609,000.00 |
| Dec 31, 2025 | 1.56 Mn |
| Dec 31, 2025 | 1.56 Mn |
| Sep 30, 2025 | -593,000.00 |
| Sep 30, 2025 | -593,000.00 |
| Jun 30, 2025 | -1.47 Mn |
| Jun 30, 2025 | -1.47 Mn |
| Mar 31, 2025 | -5.73 Mn |
| Mar 31, 2025 | -5.73 Mn |
| Dec 31, 2024 | -2.53 Mn |
| Dec 31, 2024 | -2.53 Mn |
| Sep 30, 2024 | 2.33 Mn |
| Sep 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 6.73 Mn |
| Jun 30, 2024 | 6.73 Mn |
| Mar 31, 2024 | -564,000.00 |
| Mar 31, 2024 | -564,000.00 |